Profil
Chuck Yon was the founder of Checkmate Pharmaceuticals, Inc. founded in 2015, where he held the title of General Counsel from 2015 to 2021.
Mr. Yon's former jobs include Secretary, Senior Vice President & General Counsel at Coley Pharmaceutical Group, Inc. from 2001 to 2008, and Senior Vice President & General Counsel at Astra Pharmaceutical Products, Inc. from 1989 to 1999.
Mr. Yon's education history includes a graduate degree from Georgetown University Law Center, an MBA from Kellogg School of Management, and a graduate degree from Harvard College.
Tidigare kända positioner av Chuck Yon
| Företag | Position | Slut |
|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Grundare | 2021-01-04 |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat chronic diseases | Generell Rådgivare | 2008-01-01 |
Astra Pharmaceutical Products, Inc. | Generell Rådgivare | 1999-01-01 |
Chuck Yons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat chronic diseases | Health Technology |
Astra Pharmaceutical Products, Inc. | |
Georgetown University Law Center
Georgetown University Law Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Checkmate Pharmaceuticals, Inc.
Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develop anti-cancer therapeutics | Health Technology |
















